Niroshan Nadarajah Selected Research

Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria)

1/2023

Molecular landscape of immune pressure and escape in aplastic anemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Niroshan Nadarajah Research Topics

Disease

6	Neoplasms (Cancer) 01/2023 - 02/2016
3	Hematologic Neoplasms (Hematological Malignancy) 01/2020 - 04/2018
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020 - 05/2012
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 03/2024
1	idiopathic Aplastic anemia 01/2023
1	Stroke (Strokes) 01/2023
1	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 01/2023
1	Lymphoma (Lymphomas) 01/2022
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2022
1	Residual Neoplasm 11/2018
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2016

Drug/Important Bio-Agent (IBA)

3	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2018
2	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 01/2019
2	Transcription Factors (Transcription Factor)IBA 01/2022 - 02/2016
2	RNA Splicing FactorsIBA 01/2021 - 01/2020
1	OMS 2017IBA 03/2024
1	AntigensIBA 01/2023
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2023
1	Amino Acids FDA Link 01/2022
1	Mutant Proteins (Protein, Mutant)IBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	RNA Precursors (Precursor, mRNA)IBA 01/2021
1	ChromatinIBA 01/2020
1	venetoclaxIBA 04/2018
1	Phosphotransferases (Kinase)IBA 01/2016
1	Tyrosine Kinase InhibitorsIBA 01/2016
1	CCAAT-Enhancer-Binding ProteinsIBA 05/2012

Therapy/Procedure

2	Therapeutics 01/2023 - 01/2020
1	Secondary Prevention 01/2023
1	Aftercare (After-Treatment) 01/2020
1	Induction Chemotherapy 11/2018